Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Agilon Health’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053355
FAQ
- What is Agilon Health's D&A?
- Agilon Health (AGL) reported D&A of $6.86M in Q2 2026.
- How has Agilon Health's D&A changed year-over-year?
- Agilon Health's D&A decreased by 6.2% year-over-year, from $7.32M to $6.86M.
- What is the long-term trend for Agilon Health's D&A?
- Over 4 years (2021 to 2025), Agilon Health's D&A has grown at a 18.2% compound annual growth rate (CAGR), from $14.67M to $28.59M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Agilon Health's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude